Did Bill Gates buy BioNTech shares?
Yes, the Bill & Melinda Gates Foundation made a direct investment in BioNTech by purchasing over 3 million ordinary shares in 2019. This investment, valued at roughly $55 million, was specifically designed to support the company’s research and development efforts in fields like HIV and tuberculosis treatments. It is important to note that this purchase was made by the foundation as part of its mission to advance global health, rather than as a speculative play in the public stock market by Bill Gates personally. The foundation has maintained a specific R&D-linked agreement with the company to ensure that the partnership furthers their specific scientific goals in preventing infectious diseases.
Related FAQs
Pharmaceutical stocks are often considered a solid investment choice for portfolios seeking defensive stability, steady dividend yields, and long-term growth driven by aging global populations and continuous medical innovation.
Bill Gates has not bought Costco as a company, but the Bill & Melinda Gates Foundation has held shares of Costco Wholesale in its investment portfolio for many years.
No, BioNTech SE does not pay a regular dividend. While the company issued a special, one-time dividend in 2022 following a period of high revenue, it has not established a recurring dividend program.
No, Brookfield Infrastructure Partners L.P. (BIP) does not pay monthly dividends; it operates on a quarterly distribution schedule. These distributions are typically paid in March, June, September, and December.
Boyd Gaming Corporation, a premier nationwide multi-jurisdictional gaming and entertainment company operating dozens of casino resort properties across the United States, generates substantial annual financial revenues.